methotrexate
Term · Oncology and biomedicine · MLC-T-ONC-015127
An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.
| Identifier | MLC-T-ONC-015127 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MTX |
| Synonyms | alpha-methopterin; amethopterin; methotrexate LPF; methotrexate methylaminopterin; methotrexatum; metotrexato; Rheumatrex |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015127",
"term": "methotrexate",
"field": "Oncology and biomedicine",
"definition": "An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.",
"abbreviation": "MTX",
"synonyms": [
"alpha-methopterin",
"amethopterin",
"methotrexate LPF",
"methotrexate methylaminopterin",
"methotrexatum",
"metotrexato",
"Rheumatrex"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/methotrexate/"
}
Record 10,938 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.